© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Donanemab Showed Sustained Cognitive Benefit Over 3 Years in Early Alzheimer Disease
July 30, 2025
Three-year follow-up data from the TRAILBLAZER-ALZ 2 extension trial supported early initiation and limited-duration dosing.
Alzheimer's Association Releases First Clinical Guideline on Use of Blood-Based Biomarker Tests
July 30, 2025
The guideline is the first in a series that will focus on diagnosis, treatment, and care of Alzheimer disease and all other dementias, according to the association.
Why 4 Medical Societies Issued a Joint Advisory on Nutrition and GLP-1 Therapy for Obesity
July 29, 2025
Coauthor of a recent joint advisory, Jonathan Bonnet, MD, MPH, explains how it emerged in response to the growing use of GLP-1 medications for obesity treatment.
Remote Cognitive Screening Platform Expands Access to Early Detection
July 29, 2025
Linus Health is expanding its AI-powered remote cognitive assessment platform, Anywhere, to expand access to early detection of cognitive impairment.
Trontinemab Phase 3 Alzheimer Trials to Launch Following Promising Amyloid Clearance Data
July 28, 2025
Data from Roche presented at AAIC 2025 highlight rapid amyloid clearance with investigational antibody and potential of pTau217 as blood-based rule-in and rule-out test.
Impact of Social Stigma on Mental Health among Women with Obesity: An Expert’s View
July 28, 2025
Shagun Bindlish, MD, board member of the ADA, discusses how societal weight-related stigma contributes to mental health challenges faced by women with obesity.
The Obesity–Cardiometabolic Link: Root Causes, Screening, and Primary Care's Role
July 25, 2025
Obesity medicine specialist Monu Khanna, MD, discusses the critical role of primary care in obesity-related risk reduction through lifestyle, behavior, and emerging therapies.
In Screening for Dementia, Time Can Tell A Lot: A Conversation with Researcher David Libon, PhD
July 25, 2025
In this short conversation, Libon underscores how time-based measures during assessment can reflect subtle neurocognitive changes, augmenting traditional screening.
Intranasal Epinephrine Should Be Prescribed with Confidence, Editorial Encourages
July 25, 2025
Clinical skepticism about the parity in effectiveness of epinephrine delivered via nasal spray vs autoinjector is rooted in fixed assumptions that bear examination, authors say.
FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms
July 25, 2025
Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.